BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 1347738)

  • 1. Hypothalamic preprosomatostatin messenger ribonucleic acid expression in mice transgenic for excess or deficient endogenous growth hormone.
    Hurley DL; Phelps CJ
    Endocrinology; 1992 Apr; 130(4):1809-15. PubMed ID: 1347738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
    Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
    Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered growth hormone-releasing hormone mRNA expression in transgenic mice with excess or deficient endogenous growth hormone.
    Hurley DL; Phelps CJ
    Mol Cell Neurosci; 1993 Jun; 4(3):237-44. PubMed ID: 19912928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative regulation of hypothalamic growth hormone-releasing factor messenger ribonucleic acid by growth hormone and insulin-like growth factor I.
    Uchiyama T; Kaji H; Abe H; Chihara K
    Neuroendocrinology; 1994 May; 59(5):441-50. PubMed ID: 7912818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of food deprivation in the rat on hypothalamic expression of growth hormone-releasing factor and somatostatin.
    Bruno JF; Olchovsky D; White JD; Leidy JW; Song J; Berelowitz M
    Endocrinology; 1990 Nov; 127(5):2111-6. PubMed ID: 1977579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic dopaminergic neurons in transgenic dwarf mice: histofluorescence, immunocytochemical, and in situ hybridization studies.
    Phelps CJ; Carlson S; Hurley DL
    Anat Rec; 1991 Dec; 231(4):446-56. PubMed ID: 1686535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteamine-induced enhancement of growth hormone-releasing factor (GRF) immunoreactivity in arcuate neurons: morphological evidence for putative somatostatin/GRF interactions within hypothalamus.
    Tannenbaum GS; McCarthy GF; Zeitler P; Beaudet A
    Endocrinology; 1990 Nov; 127(5):2551-60. PubMed ID: 1977581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypophysiotropic somatostatin expression during postnatal development in growth hormone-deficient Ames dwarf mice: mRNA in situ hybridization.
    Hurley DL; Wee BE; Phelps CJ
    Neuroendocrinology; 1997 Feb; 65(2):98-106. PubMed ID: 9067987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
    Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M
    Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autofeedback suppression of growth hormone (GH) secretion in transgenic mice expressing a human GH reporter targeted by tyrosine hydroxylase 5'-flanking sequences to the hypothalamus.
    Szabo M; Butz MR; Banerjee SA; Chikaraishi DM; Frohman LA
    Endocrinology; 1995 Sep; 136(9):4044-8. PubMed ID: 7649113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased hypothalamic somatostatin expression in mice transgenic for bovine or human GH.
    Hurley DL; Bartke A; Wagner TE; Wee BE; Phelps CJ
    J Neuroendocrinol; 1994 Oct; 6(5):539-48. PubMed ID: 7827624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulation of growth hormone-releasing hormone gene expression and secretion].
    Katakami H; Matsukura S
    Nihon Naibunpi Gakkai Zasshi; 1992 Oct; 68(10):1057-72. PubMed ID: 1360909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A possible role of hypothalamic somatostatin in the maintenance of rat pituitary responsiveness to growth hormone-releasing factor.
    Soya H; Suzuki M
    Endocrinology; 1990 Jan; 126(1):285-91. PubMed ID: 1967163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice.
    Park S; Peng XD; Frohman LA; Kineman RD
    Neuroendocrinology; 2005; 81(6):360-71. PubMed ID: 16244497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of pituitary somatostatin receptor subtype (sst1-5) messenger ribonucleic acid levels by changes in the growth hormone axis.
    Park S; Kamegai J; Johnson TA; Frohman LA; Kineman RD
    Endocrinology; 2000 Oct; 141(10):3556-63. PubMed ID: 11014208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrelationship between the novel peptide ghrelin and somatostatin/growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion.
    Tannenbaum GS; Epelbaum J; Bowers CY
    Endocrinology; 2003 Mar; 144(3):967-74. PubMed ID: 12586774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of hypophysectomy and growth hormone administration on pre-prosomatostatin messenger ribonucleic acid in the periventricular nucleus of the rat hypothalamus.
    Rogers KV; Vician L; Steiner RA; Clifton DK
    Endocrinology; 1988 Feb; 122(2):586-91. PubMed ID: 2892665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deprivation of growth hormone-releasing hormone early in the rat's neonatal life permanently affects somatotropic function.
    Cella SG; Locatelli V; Mennini T; Zanini A; Bendotti C; Forloni GL; Fumagalli G; Arce VM; de Gennaro Colonna V; Wehrenberg WB
    Endocrinology; 1990 Oct; 127(4):1625-34. PubMed ID: 1976092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of central and peripheral administration of growth hormone (GH) and insulin-like growth factor on hypothalamic GH-releasing hormone and somatostatin gene expression in GH-deficient dwarf rats.
    Sato M; Frohman LA
    Endocrinology; 1993 Aug; 133(2):793-9. PubMed ID: 8102097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypophysiotropic somatostatin expression during postnatal development in growth hormone-deficient Ames dwarf mice: peptide immunocytochemistry.
    Phelps CJ; Saleh MN; Romero MI
    Neuroendocrinology; 1996 Nov; 64(5):364-78. PubMed ID: 8930937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.